#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Castleman's disease Dementia Transitional cell carcinoma B-cell small lymphocytic lymphoma Hepatic cirrhosis Inclusion body myositis Glomerulonephritis chronic Rett syndrome Small cell lung cancer PIK3CA related overgrowth spectrum Hepato-lenticular degeneration Cardiac arrest Ocular lymphoma Philadelphia chromosome positive Acute graft versus host disease in intestine More trials…

    Learn about Rare Diseases

    Pemphigoid – Diagnostics Mantle cell lymphoma stage II Focal segmental glomerulosclerosis – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Acute respiratory distress syndrome – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics Advanced systemic mastocytosis – Treatment Retinoblastoma – Treatment Retinoblastoma Congenital hypotransferrinaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BROLUCIZUMAB Losartan Potassium LTG-001 RIMIDUCID Ht-29-B Onfekafusp Alfa Gefitinib Rasagiline Tecaginlimab Citalopram L-ARGININE Semaglutide Emiplacel Diltiazem FERUMOXTRAN-10 Irinotecan Hydrochloride Ecoo16 Daptomycin Sodium Laurilsulfate Navtemadlin More therapies…

    Learn about Your Condition

    Dementia Mental disorder Raynaud's phenomenon Bacterial infection Deafness traumatic Spinal cord injury Migraine without aura Pneumonia bacterial Amyotrophic lateral sclerosis Pterygium Erythema migrans Nephroblastoma Adrenoleukodystrophy Cognitive disorder Osteonecrosis of jaw More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rheumatoid arthritis

  • Study on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Burfiralimab
    Austria Czechia Hungary The Netherlands Poland Spain

  • Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    • Methotrexate
    Bulgaria Czechia Estonia Hungary Latvia Lithuania +2

  • Study on the Effects of Baricitinib in Early-Stage Rheumatoid Arthritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Baricitinib
    Germany

  • Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    Austria Italy Norway Romania Sweden

  • Study on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Methotrexate
    Portugal

  • Study on the Effectiveness and Tolerability of Oral vs. Subcutaneous Methotrexate for Patients with Early Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Methotrexate
    Sweden
Previous Page
1 … 9 10 11 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!